Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income	$ 327.7	$ 455.4
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation	180.4	153.8
Deferred debt issuance cost amortization	2.2	2.6
Amortization of intangibles	30.4	35.9
Amortization of debt discount	0	6.9
Stock compensation	(11.0)	33.9
Equity in net earnings of affiliates, net of cash received	(28.6)	(22.5)
Deferred income tax provision	1.7	28.1
Other	2.3	0.2
Changes in operating assets and liabilities, net of effects from purchase of businesses:
Accounts and notes receivable, net	(151.4)	(245.5)
Inventories, net	(422.7)	(507.9)
Other current and noncurrent assets	(0.8)	(22.8)
Accounts payable	(74.7)	95.3
Accrued expenses	(96.9)	98.0
Other current and noncurrent liabilities	26.1	57.6
Total adjustments	(543.0)	(286.4)
Net cash (used in) provided by operating activities	(215.3)	169.0
Cash flows from investing activities:
Purchases of property, plant and equipment	(229.3)	(263.8)
Proceeds from sale of property, plant and equipment	2.2	2.9
Purchase of business, net of cash acquired	(130.4)	(0.1)
Sale of (investment in) unconsolidated affiliates, net	0	0.1
Net cash used in investing activities	(357.5)	(260.9)
Cash flows from financing activities:
Purchases and retirement of common stock	(340.9)	(1.0)
Proceeds from debt obligations, net	450.6	4.1
Repurchase or conversion of convertible senior subordinated notes	(201.2)	0
Payment of dividends to stockholders	(30.9)	(29.1)
Payment of minimum tax withholdings on stock compensation	(11.9)	(16.3)
Purchase of or distribution to noncontrolling interests	(6.1)	(2.6)
Payment of debt issuance costs	(1.3)	0
Net cash used in financing activities	(141.7)	(44.9)
Effects of exchange rate changes on cash and cash equivalents	(11.8)	(24.0)
Decrease in cash and cash equivalents	(726.3)	(160.8)
Cash and cash equivalents, beginning of period	1,047.2	781.3
Cash and cash equivalents, end of period	$ 320.9	$ 620.5